Willis Towers Watson (WTW) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved 5% organic revenue growth and 150 basis points of adjusted operating margin expansion in Q2 2025, with adjusted EPS up 20% year-over-year to $2.86 and diluted EPS up 144% to $3.32.
Net income rose 135% to $331M for the quarter, driven by cost reductions and operational efficiencies.
Results reflect progress on strategic objectives, resilience amid macroeconomic and geopolitical uncertainty, and strong execution in both organic and inorganic growth strategies.
Technology and AI investments are driving measurable efficiency gains and client value, with notable adoption of global broking platforms and AI-powered tools.
Strong new business wins in specialty, technology, and global collaboration, with expansion in the Middle East and data center construction sectors.
Financial highlights
Q2 2025 revenue was $2.26B, flat year-over-year; organic revenue up 5%.
Net income for Q2 2025 was $332M, up from $142M in Q2 2024.
Adjusted operating margin reached 18.5%, up 150 basis points; adjusted EBITDA margin was 20.8%, up from 19.6%.
Free cash flow for the first half was $217M, down from $305M year-over-year due to higher incentive costs, tax payments, and absence of TRANZACT inflows.
Returned $591M to shareholders in Q2 via $500M in share repurchases and $91M in dividends.
Outlook and guidance
On track to deliver full-year 2025 guidance: mid-single-digit organic growth, adjusted operating margin expansion, adjusted EPS growth, and ongoing free cash flow margin improvement.
Risk & Broking expected to achieve mid to high single-digit organic growth and ~100 basis points of average annual margin expansion over the next three years.
Health, Wealth & Career expected to deliver incremental annual margin expansion.
Expecting ~$1.5B in share repurchases for 2025, subject to market and investment opportunities.
Foreign currency expected to provide a $0.05 tailwind to adjusted diluted EPS in 2025.
Latest events from Willis Towers Watson
- Q2 saw 6% organic growth, margin expansion, and raised 2024 guidance with strong capital returns.WTW
Q2 20248 Jul 2026 - 5% organic growth and margin gains offset TRANZACT sale, driving higher net income.WTW
Q1 20258 Jul 2026 - 5% organic growth, margin gains, and $473M in savings set up for continued strong performance.WTW
Q4 20248 Jul 2026 - Organic growth and margin expansion offset divestiture impacts, boosting adjusted EPS and cash flow.WTW
Q4 20258 Jul 2026 - Revenue up 8%, adjusted EPS up 19%, with margin expansion and $300M in buybacks.WTW
Q1 202630 Apr 2026 - Six major proposals, board refreshment, strong performance, and enhanced risk oversight highlighted.WTW
Proxy filing27 Mar 2026 - Key votes include director elections, auditor ratification, and share plan amendments.WTW
Proxy filing27 Mar 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WTW
Q3 202417 Jan 2026 - Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WTW
CMD 202412 Jan 2026